Dr. Daniel Kurbanov, MD

Dr. Kurbanov is Board Certified in Internal Medicine and Pulmonary Medicine, and Board Eligible in Critical Care Medicine. He completed his internal medicine residency at NYU Winthrop Hospital and completed a fellowship in Pulmonary and Critical Care Medicine at Yale University School of Medicine.

Education

Medical School - Technion–Israel Institute of Technology, Haifa, Israel, Graduated: 2014

Residency - NYU Winthrop Hospital, Mineola, NY, Internal Medicine, 2014-2017

Fellowship - Yale University School of Medicine, New Haven, CT, Pulmonary and Critical Care Medicine, 2017-2020

Certifications and Affiliations
  • Board Certified, Internal Medicine, Pulmonary Medicine

  • Board Eligible, Critical Care Medicine

  • American Thoracic Society, American College of Chest Physicians

  • Advanced Cardiac Life Support (ACLS)

Awards and Grants
  • NHLBI T32, Translational Lung Biology and Pathobiology, July 2018-June 2020

  • John Aloia, M.D. Award for Academic Excellence, NYU Winthrop Hospital, June 2017

  • Resident of the Year Award (Internal Medicine), NYU Winthrop Hospital June 2016

  • Pulmonary Fibrosis Research Grant, Mother Mary Breath Easy, Inc, 2016

Research and Publications
  • Kurbanov, D., Ahangari, F., Xylourgidis, N., McDonough, J.E., Wuyts, W., Vanaudenaerde, B.M., Levine, M., Kaminski, N. Epigenetic Age Acceleration in Idiopathic Pulmonary Fibrosis. [abstract]. ATS 2019

  • Nair, G.B., Matela, A., Kurbanov, D., and Raghu, G. (2016). Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications. Expert Review of Respiratory Medicine, 10(6):699-711

  • Osahan, D., Aparnath, M., Desai, A., Kurbanov, D., Salzman, D., Chawla, S., Spiegler, P., and Mathew, J.P. Diagnostic Accuracy and Complication Rates after Implementation of an Electromagnetic Navigation Bronchoscopy Program at an Academic Teaching Hospital. [abstract]. CHEST 2017

  • Papik, F., Nair, G., Yeturu, P., Kurbanov, D., Fazzari, M.J., and Niederman, M. An Exploration of De-Escalation Strategies in Hospitalized Patients with Community Acquired Pneumonia. AJRCCM 193, A62. Clinical Aspects of CAP, HCAP, HAP, and VAP, A2119-A2119. [abstract]. ATS 2016

  • Yeturu, P.R., Kurbanov, D., Cheriyan, C., Pang, J., Fazzari, M.J., and Nair, G.B. Relationship of Serum Sodium Level to Adverse Outcomes in Patients with Interstitial Lung Disease AJRCCM 193, C39. IPF: More on Diagnosis and Therapy, A4987-A4987. [abstract]. ATS 2016

daniel_kurbanov_md.jpg